Abstract
ADVERTISEMENT RETURN TO ISSUEPREVViewpointTherapeutics for Neglected Infectious Diseases: Progress and ChallengePei-Yong Shi*, Paul W. Smith, and Thierry T. DiaganaView Author Information Novartis Institute for Tropical Diseases, 10 Biopolis Road, 05-01 Chromos, Singapore 138670*(P.-Y.S.) E-mail: [email protected]Cite this: ACS Infect. Dis. 2015, 1, 1, 76–78Publication Date (Web):January 9, 2015Publication History Received15 December 2014Published online9 January 2015Published inissue 9 January 2015https://pubs.acs.org/doi/10.1021/id500043rhttps://doi.org/10.1021/id500043rarticle-commentaryACS PublicationsCopyright © 2015 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views988Altmetric-Citations8LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (149 KB) Get e-AlertscloseSUBJECTS:Antimicrobial agents,Infectious diseases,Parasites,Pharmaceuticals,Therapeutics Get e-Alerts